Opinions
Bruce Campbell (2)
Greenbrook TMS
GTMS-T
TOP PICK
May 01, 2019
Their technology treats depression that's non-invasive. GTMS rolled out laser eye centres in the 1990s. They're growing in the U.S. rapidly. (Analysts’ price target is $6.00)
$3.280
Stock price when the opinion was issued
medical services
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
PAST TOP PICK
(A Top Pick May 01/19, Down 51%) This was impacted along with the entire cannabis space. He got stopped out and took a small loss. They are into magnetic stimulation of the brain. Much like laser eye surgery, he thinks there is great opportunity going forward. It should be on your radar.
medical services
Advertising